http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EA-201170613-A1

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-705
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6872
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-0459
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K51-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-60
filingDate 2009-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2011-12-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EA-201170613-A1
titleOfInvention USE OF 7-chloro-N, N, 5-trimethyl-4-oxo-3-phenyl-3,5-dihydro-4H-pyridazino [4,5-b] indole-1-acetamide as a biomarker peripheral benzodiazepine RECEPTOR LEVELS
abstract Use of the radiolabeled form 7-chloro-N, N, 5-trimethyl-4-oxo-3-phenyl-3,5-dihydro-4H-pyridazine [4,5-b] indole-1-acetamide as a biomarker determining in a patient the levels of PBR associated with normal and pathological conditions. A method for determining PBR levels associated with normal and pathological conditions. Diagnostic kit.
priorityDate 2008-10-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419495236
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9930560
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420424229
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4408257

Total number of triples: 21.